These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7108447)
1. The relationship of HDL-apolipoprotein A-I and HDL-Cholesterol to risk factors of coronary heart disease: initial results of the prospective epidemiological study in company employees in Westfalia. Assmann G; Funke H; Schriewer H J Clin Chem Clin Biochem; 1982 May; 20(5):287-9. PubMed ID: 7108447 [TBL] [Abstract][Full Text] [Related]
2. The relationship of lipoprotein (a) (Lp(a)) to risk factors of coronary heart disease: initial results of the prospective epidemiological study on company employees in Westfalia. Schriewer H; Assmann G; Sandkamp M; Schulte H J Clin Chem Clin Biochem; 1984 Sep; 22(9):591-6. PubMed ID: 6491620 [TBL] [Abstract][Full Text] [Related]
3. HDL apolipoprotein A-I and HDL apolipoprotein A-II concentrations in male company employees in Westphalia aged 40 years and older. Schriewer H; Emke F; Funke H; Schulte H; Assmann G J Clin Chem Clin Biochem; 1986 Sep; 24(9):627-35. PubMed ID: 3095483 [TBL] [Abstract][Full Text] [Related]
4. The effects of cigarette smoking on serum levels of HDL cholesterol and HDL apolipoprotein A-I. Findings of a prospective epidemiological study on employees of several companies in Westphalia, West Germany. Assmann G; Schulte H; Schriewer H J Clin Chem Clin Biochem; 1984 Jun; 22(6):397-402. PubMed ID: 6434692 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. Maciejko JJ; Holmes DR; Kottke BA; Zinsmeister AR; Dinh DM; Mao SJ N Engl J Med; 1983 Aug; 309(7):385-9. PubMed ID: 6410239 [TBL] [Abstract][Full Text] [Related]
7. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843 [TBL] [Abstract][Full Text] [Related]
8. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. Kukita H; Hiwada K; Kokubu T Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307 [TBL] [Abstract][Full Text] [Related]
9. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries. Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991 [No Abstract] [Full Text] [Related]
10. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. Kempen HJ; van Gent CM; Buytenhek R; Buis B J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. Genest J; McNamara JR; Ordovas JM; Jenner JL; Silberman SR; Anderson KM; Wilson PW; Salem DN; Schaefer EJ J Am Coll Cardiol; 1992 Mar; 19(4):792-802. PubMed ID: 1531990 [TBL] [Abstract][Full Text] [Related]
13. Lipid and apolipoprotein levels in an Australian community. Kinlay S; Dobson AJ; Heller RF; Dickeson JE; Ryan S Med J Aust; 1991 Feb; 154(3):170-5. PubMed ID: 1988787 [TBL] [Abstract][Full Text] [Related]
14. Effects of age and cigarette smoking on serum concentrations of lipids and apolipoproteins in a male military population. Cuesta C; Sánchez-Muniz FJ; García-La Cuesta A; Garrido R; Castro A; San-Felix B; Domingo A Atherosclerosis; 1989 Nov; 80(1):33-9. PubMed ID: 2604755 [TBL] [Abstract][Full Text] [Related]
15. Discriminative value of lipids and apoproteins in coronary heart disease. De Backer G; Rosseneu M; Deslypere JP Atherosclerosis; 1982 Apr; 42(2-3):197-203. PubMed ID: 6803813 [TBL] [Abstract][Full Text] [Related]
16. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a). Genest JJ; McNamara JR; Ordovas JM; Martin-Munley S; Jenner JL; Millar J; Salem DN; Schaefer EJ Am J Cardiol; 1990 Mar; 65(9):677-9. PubMed ID: 2106773 [No Abstract] [Full Text] [Related]
17. [Accuracy of HDL-cholesterol and HDL-apolipoprotein A-I determinations after phosphotungstate/MgCl2-precipitation of apolipoprotein B-containing lipoproteins (author's transl)]. Assmann G; Schriewer H; Funke H J Clin Chem Clin Biochem; 1981 May; 19(5):273-8. PubMed ID: 6790659 [TBL] [Abstract][Full Text] [Related]
18. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Onat A; Can G; Ayhan E; Kaya Z; Hergenç G Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555 [TBL] [Abstract][Full Text] [Related]
19. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins. Luoma PV; Marniemi J; Sotaniemi EA Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720 [TBL] [Abstract][Full Text] [Related]
20. Progress in coronary artery disease risk-factor research: what remains to be done? Crouse JR Clin Chem; 1984 Jul; 30(7):1125-7. PubMed ID: 6428775 [No Abstract] [Full Text] [Related] [Next] [New Search]